Financial aspects minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempted from such publication. The Medical Facility is obliged to publish this Amendment No. 2 together with the Agreement and the Amendment No. 1 in accordance with the article herein above. Should the Medical Facility fail to publish this Amendment No. 2 together with the Agreement and the Amendment No. 1 within 15 working days from its full execution, it may be published by the Contractual research organization or Sponsor. The estimated value of financial payment under the Agreement, as amended, shall be approximately CZK 203 025. 3. This Amendment No. 2 has been written in four counterparts, each contracting party obtaining one of them. 4. In witness of their consent to the wording hereof, the Parties sign this Amendment No. 2. předchozí věty odpovídá Zdravotnické zařízení. Takovémuto zveřejnění nepodléhají ty údaje, které tvoří obchodní tajemství některé ze smluvních stran. Pro účely dodatků a Smlouvy se obchodním tajemstvím rozumí zejména Článek XIII. “Finanční aspekty”, minimální cílový počet zařazení, očekávaný zařazený počet subjektů a očekávaná délka trvání Studie. Xxxx nebudou takovémuto zveřejnění podléhat osobní údaje fyzických osob. Za zveřejnění tohoto Dodatku č. 2 společně se Smlouvou a Dodatkem č. 1 dle předchozího odstavce odpovídá Zdravotnické zařízení. Není-li Dodatek č. 2 společně se Smlouvou a Dodatkem č. 1 zveřejněn Zdravotnickým zařízením ve lhůtě 15 pracovních dní od podpisu Dodatku č. 2 všemi smluvními stranami, jsou k jeho zveřejnění oprávněni Smluvní výzkumná organizace či Zadavatel. Předpokládaná hodnota finančního plnění dle Smlouvy ve znění Dodatku č. 2 činí přibližně 203 025 Kč. 3. Tento Dodatek č. 2 byl vyhotoven ve čtyřech stejnopisech, přičemž xxxxx smluvní strana obdrží po jednom. 4. Na důkaz souhlasu se zněním Dodatku č. 2 připojují Strany své podpisy.
Financial aspects is hereby deleted in its entirety and replaced as follows: “Finanční aspekty” se tímto ruší v celém rozsahu a nahrazuje následujícím zněním:
Financial aspects minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempted from such publication, unless they have been previously published in another public register. The Medical Facility is obliged to publish *Bude proplaceno po obdržení vyplněných eCRFs. Článek II.
Examples of Financial aspects in a sentence
Item Financial aspects (B10) Statutory taxes, duties and levies (B10.1) F:........................
Item Financial aspects (B10) Statutory taxes, duties and levies (B10.1)F:.............................
Item Financial aspects (B10) Statutory taxes, duties and levies (B10.1) F:.............................
Financial aspects (B10) 89 Statutory taxes, duties and levies (B10.1) Item F:..............................
Section No. 1 PRELIMINARIES Bill No. 1 Preliminaries Zethu Consulting Services Financial aspects (B10) Statutory taxes, duties and levies (B10.1)F:.............................
Financial aspects Open a bank account specific to the project at the start of the project.
Financial aspects Provide financial support to the project with the support of the Luxembourg Ministry of Foreign Affairs (MFA) in accordance with the following table: Name of Luxembourg NGO Ministry of Foreign Affairs Name of partner NGO Total Year 1 Year 2 Year 3 Transfer to Name of partner NGO, upon receipt of the full narrative and financial reports and invoices, the following sums: For the first year: € ………….
Financial aspects (B10) Statutory taxes, duties and levies (B10.1) F:..............................
Financial aspects of the event Any expenditure involved with the conduct of your event and any disposition of funds and profits resulting from the event must be properly authorised by MS be- fore the commencement of the event.
Financial aspects (Annexe II) The financial aspects shall be described in the financial memorandum that appears in Annexe II of the contract, as an inseparable part thereof.
More Definitions of Financial aspects
Financial aspects minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempted from such publication, unless they have been previously published in another public register. The Medical Facility is obliged to publish this Amendment No. 2 together with the Agreement and the Amendment No. 1 in accordance with the article herein above. The Medical Facility will inform Contractual research organization of publishing the Amendment No. 2 together with the Agreement and the Amendment No. 1 by designating the following email address: as the email address to which a notification of publication in the Agreements register shall be sent. Should the Medical Facility fail to publish this Amendment No. 2 together with the Agreement and the Amendment No. 1 within 15 working days from its full execution, it may be published by the Contractual research organization or Sponsor. The estimated value of financial payment under the Agreement, as amended, shall be approximately CZK 101419.
Financial aspects is hereby deleted in its entirety and replaced as follows: The payment schedule: Visit Payment per subject for each completed Visit (CZK) Screening visit XXXX Visit 18 phone call XXXX Visit 26 phone call XXXX Visit 30 XXXX Visit 34 phone call XXXX Visit 38 XXXX Visit 42 phone call XXXX Visit 50 phone call XXXX Visit 54 XXXX Unscheduled Visit / Decision to Switch to OLE XXXX Early Withdrawal / End of Washout XXXX 12-Week Safety Follow Up Week 6 XXXX Week 12 / Early termination XXXX Unscheduled Visit XXXX INVOICED ITEMS: Unit Cost (including OH) (CZK) Serum pregnancy test XXXX Urine pregnancy test XXXX Chest X-ray, includes interpretation and report XXXX TB screen (QuantiFeron - TB Gold Test) XXXX TB screen (Skin Test) XXXX Colonoscopy, with biopsy XXXX Sigmoidoscopy, with biopsy XXXX Etrolizumab / etrolizumab dummy XXXX Clinic Visits for weeks 16, 20, 24, 28, 32, 36, 40, 44, 48, 52 if Etrolizumab / etrolizumab dummy to be administered on site XXXX PML Neurologic Examination XXXX Central Labs (Hematology, Chemistry) XXXX Urinalysis XXXX PK sampling (serum) XXXX Central Labs (Anti-therapeutic antibody, CRP) includes Collection, Preparation and Processing XXXX Stool sample collection XXXX Colonic biopsy (CMV) XXXX Colonic biopsies (formalin, for qPCR) XXXX Colonic biopsy (histopathological confirmation of UC) XXXX Biopsy; Staining and preparation of the slides including shipping and handling XXXX Neurologist - Per Hour XXXX Brain MRI with contrast, includes interpretation and report XXXX Brain MRI without contrast, includes interpretation and report XXXX Lumbar puncture XXXX Cerebrospinal fluid (CSF) analysis for JCV by PCR XXXX Reconsenting Fee XXXX Screen Failure XXXX
Financial aspects. Budget and payment schedule, minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempted from such publication, unless they have been previously published in another public register. The Medical Facility is obliged to publish this Amendment No. 2 together with the Agreement in accordance with the article herein above. The Medical Facility will inform the Contractual research organization of publishing the Amendment No. 2 together with the Agreement by designating the following email address: xxxxxxxxxxxx@xxxxxxxxx.xxx as the email address to which a notification of publication in the Agreements register shall be sent. Should the Medical Facility fail to publish this Amendment No. 2 together with the Agreement within 5 working days from its full execution, it may be published by the Sponsor or Contractual research organization. The estimated value of financial payment under the Agreement, as amended, shall be approximately CZK XXXXXXXXXXX
Financial aspects is hereby deleted in its entirety and replaced as follows: The payment schedule:Visit Payment per subject for each completed Visit (CZK) XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX Total XXXXX INVOICED ITEMS: Unit Cost (CZK) XXXXXXXXXXXX XXXXX Total new contract value is CZK 17500655.
Financial aspects. The Council recognises that it is only a contributing partner to the funding needed by Martock Youth Centre and Martock Parish Council. Much of the balance is raised from the Parish Council precept. • The purpose of SSDC Area North funding is to ensure access to a range of activities and dedicated support services for young people in Martock, supporting the delivery of a key project within the Martock Local Community Plan 2007 and priorities within the Area North Area Development Plan and the Somerset Local Area Agreement. • The funding agreement assumes no significant changes in the level or scope of core activity over the life of the project. Any significant budget changes should be notified by January 30 of each year. • SSDC’s standard grant conditions will be in place (Appendix A). Support Arrangements: • The lead officer and first point of contact regarding this agreement will be the Head of Area Development North. • All efforts will be made to offer practical advice and support to Martock Parish Council and Martock Youth Centre beyond the core funding detailed above. • In the case of any dispute/concern relating to the agreement with or the relationship with Area North, this should be raised with the Head of Area Development North. If the problem is not resolved then this should be raised with the Corporate Director or Portfolio Holder. Signatures ………………………………………………………… for Martock Parish Council DATED………………………………... ………………………………………………………… for Martock Youth Centre DATED………………………………... ……………………………………………………… for South Somerset District Council
Financial aspects is hereby deleted in its entirety and replaced as follows: The payment schedule: Visit Payment per subject for each completed Visit (CZK) XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX XXXXXXXXXXXX XXXXX INVOICED ITEMS: Unit Cost (including OH) (CZK) XXXXXXXXXXXX XXXXX Screening Failure Contractual research organization will pay the Medical Facility up to 5 screening failure patients, in a ratio of 2:1 (2 screen failure patients to be paid for every 1 randomized patient). If the site reaches the cap of 5 screen failure, it should be discussed with relevant CPM before more patients can be screened. To be eligible for reimbursement of screening visit, visit must be logged as a screening failure in IVRS and screening labs performed must be confirmed by lab report. In addition, Medical Facility must provide to Contractual research organization any additional information, which may be requested by Contractual research organization to appropriately document the subject screening procedures. No eCRFs will be collected for screening failure visits and invoices should not be submitted for reimbursement. Prescreening activities To recognize Site’s efforts in the Study prescreening procedures, Contractual research organization will compensate Medical Facility XXXX CZK for each subject screened and randomized who was entered in the prescreening log at least 1 month before screening (the “Prescreening Payment”). To be eligible for the Prescreening Payment, Medical Facility must document that prescreening occurred at least 1 month prior to screening by submitting the prescreening log to Contractual research organization once per week. Medical Facility agrees that it will submit to Contractual research organization the prescreening log, completed screening documents, randomization CRF pages, and any additional information requested by Contractual research organization to appropriately document the subject prescreening, screening, and randomization activities. To receive the Prescreening Payment, Medical Facility shall issue an invoice to Contractual research organization containing the Patient Randomization Number of the qualifying subject Pregnancy test, alcohol and gauze: The Medical Facility is responsible for purchase of pregnancy tests, alcohol pad and gauze during the course of the trial, not to exceed XXXX CZK. Medical Facility will provide such materials to patients (study subjects) to take home for the purposes of study protocol procedures. A supply fee reimbursement for...